Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 DKK | +0.68% | +1.03% | +7.47% |
23/04 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
23/04 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
Business Summary
Number of employees: 4,000
Sales per Business
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prosthetics
50.7
%
| 3,226 | 63.4 % | 2,743 | 50.7 % | -14.96% |
Patient Care
35.7
%
| - | - | 1,930 | 35.7 % | - |
Bracing and Supports
18.6
%
| 1,861 | 36.6 % | 1,010 | 18.6 % | -45.75% |
Internal Product
-5.0
%
| - | - | -268 | -5.0 % | - |
Sales per region
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
48.9
%
| 2,483 | 48.8 % | 2,647 | 48.9 % | +6.61% |
EMEA
42.8
%
| 2,166 | 42.6 % | 2,318 | 42.8 % | +6.99% |
APAC
8.3
%
| 438 | 8.6 % | 450 | 8.3 % | +2.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 01/09/01 |
Director of Finance/CFO | 58 | 01/22/01 | |
Lukas Märklin
COO | Chief Operating Officer | - | 15/23/15 |
Chief Tech/Sci/R&D Officer | 42 | 01/09/01 | |
Investor Relations Contact | - | 01/17/01 | |
Jos Van Poorten
PRN | Corporate Officer/Principal | - | - |
Gudjon Karason
PRN | Corporate Officer/Principal | 55 | 01/98/01 |
Human Resources Officer | 46 | 01/00/01 | |
Ólafur Gylfason
PRN | Corporate Officer/Principal | 55 | 01/97/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 01/13/01 | |
Niels Jacobsen
CHM | Chairman | 66 | 01/05/01 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 01/08/01 |
Director/Board Member | 55 | 01/09/01 | |
Director/Board Member | 67 | 08/21/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 428,000,000 | 207,135,435 ( 48.40 %) | 701,647 ( 0.1639 %) | 48.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
EMBLA MEDICAL HF. 0.16% | 701,647 | 0.16% | 3,409,906 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Össur Iceland ehf
Össur Iceland ehf Medical SpecialtiesHealth Technology Part of William Demant Fonden, Össur Iceland ehf is a private company that provides non-invasive orthopedic products and support services. The company is based in Reykjavík, Iceland. |
Medical Specialties
|
Össur Finance AG
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.47% | 1.82B | |
-13.79% | 20.6B | |
-4.15% | 17.33B | |
+7.42% | 13.89B | |
+9.73% | 10.21B | |
-13.54% | 2.16B | |
+37.40% | 1.68B | |
+18.37% | 617M | |
0.00% | 434M | |
+33.65% | 154M |
- Stock Market
- Equities
- EMBLA Stock
- Company Embla Medical hf.